Clinical trial
Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA)
NCT02008721 is registered in ClinicalTrials.gov with Dr. Johannes Levin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA)
- Lead sponsor
- Dr. Johannes Levin
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- December 31, 2016
- Enrollment
- 92 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.